tiprankstipranks
Advertisement
Advertisement

ACIU Stock Latest News

AC Immune reports Q1 EPS (15c), consensus (14c)
The FlyAC Immune reports Q1 EPS (15c), consensus (14c)
14h ago
ACIU
AC Immune Triggers $12 Million Takeda Milestone as Final ABATE Cohort Starts in Alzheimer’s Trial
PremiumCompany Announcements
AC Immune Triggers $12 Million Takeda Milestone as Final ABATE Cohort Starts in Alzheimer’s Trial
16h ago
6K
ACIU
AC Immune Posts Q1 2026 Update, Extends Cash Runway and Advances Neurodegeneration Pipeline
PremiumCompany Announcements
AC Immune Posts Q1 2026 Update, Extends Cash Runway and Advances Neurodegeneration Pipeline
16h ago
6K
ACIU
Is ACIU a Buy, Before Earnings?
PremiumPre-Earnings
Is ACIU a Buy, Before Earnings?
10d ago
ACIU
Leerink calls AC Immune- Eli Lilly Tau amendment ‘great news’
PremiumThe Fly
Leerink calls AC Immune- Eli Lilly Tau amendment ‘great news’
23d ago
LLY
ACIU
AC Immune Secures Amended Tau Drug Collaboration with Lilly, Adds CHF 10 Million Upfront
PremiumCompany AnnouncementsAC Immune Secures Amended Tau Drug Collaboration with Lilly, Adds CHF 10 Million Upfront
24d ago
6K
ACIU
AC Immune announces amendment to Eli Lilly license pact, to receive CHF 10M
Premium
The Fly
AC Immune announces amendment to Eli Lilly license pact, to receive CHF 10M
24d ago
LLY
ACIU
AC Immune’s PET tracer shows efficacy detecting brain pathologies
Premium
The Fly
AC Immune’s PET tracer shows efficacy detecting brain pathologies
1M ago
ACIU
AC Immune: Advancing Neurology Pipeline and Imminent Alzheimer’s Vaccine Data Support Buy Rating
PremiumRatings
AC Immune: Advancing Neurology Pipeline and Imminent Alzheimer’s Vaccine Data Support Buy Rating
2M ago
ACIU
AC Immune: Advancing Alzheimer’s and Parkinson’s Pipeline Catalysts Underpin Buy Rating and Favorable Risk‑Reward
PremiumRatings
AC Immune: Advancing Alzheimer’s and Parkinson’s Pipeline Catalysts Underpin Buy Rating and Favorable Risk‑Reward
2M ago
ACIU
AC Immune Posts 2025 Results, Sharpens Pipeline Focus and Extends Cash Runway to 2027
PremiumCompany Announcements
AC Immune Posts 2025 Results, Sharpens Pipeline Focus and Extends Cash Runway to 2027
2M ago
6K
ACIU
AC Immune reports FY25 EPS (CHF 0.70) vs (CHF 0.51) last year
PremiumThe Fly
AC Immune reports FY25 EPS (CHF 0.70) vs (CHF 0.51) last year
2M ago
ACIU
ACIU Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsACIU Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
ACIU
AC Immune Doses First Participant in Phase 1 Trial of NLRP3 Inhibitor ACI-19764
Premium
Company Announcements
AC Immune Doses First Participant in Phase 1 Trial of NLRP3 Inhibitor ACI-19764
2M ago
6K
ACIU
AC Immune initiates Phase 1 trial of NLRP3 inhibitor
Premium
The Fly
AC Immune initiates Phase 1 trial of NLRP3 inhibitor
2M ago
ACIU
AC Immune Says Janssen Pauses Enrollment in Alzheimer’s Trial but Confirms Cash Runway to Q3 2027
PremiumCompany Announcements
AC Immune Says Janssen Pauses Enrollment in Alzheimer’s Trial but Confirms Cash Runway to Q3 2027
2M ago
6K
ACIU
Promising Advancements in Parkinson’s Treatment: AC Immune’s ACI-7104 Vaccine Shows Groundbreaking Results
PremiumRatings
Promising Advancements in Parkinson’s Treatment: AC Immune’s ACI-7104 Vaccine Shows Groundbreaking Results
5M ago
ACIU
AC Immune’s Parkinson’s disease candidate shows positive Phase 2 results
PremiumThe Fly
AC Immune’s Parkinson’s disease candidate shows positive Phase 2 results
5M ago
ACIU
AC Immune Reports Promising Phase 2 Results for Parkinson’s Therapy
PremiumCompany Announcements
AC Immune Reports Promising Phase 2 Results for Parkinson’s Therapy
5M ago
6K
ACIU
Promising Potential of AC Immune SA’s Vaccine Platform in Parkinson’s Disease: A Buy Rating by Andrew Fein
PremiumRatingsPromising Potential of AC Immune SA’s Vaccine Platform in Parkinson’s Disease: A Buy Rating by Andrew Fein
6M ago
ACIU
AC Immune SA Reports Decline in Q3 2025 Financial Results
Premium
Company Announcements
AC Immune SA Reports Decline in Q3 2025 Financial Results
6M ago
6K
ACIU
AC Immune reports Q3 EPS (CHF 0.16) vs. CHF 0.05 last year
Premium
The Fly
AC Immune reports Q3 EPS (CHF 0.16) vs. CHF 0.05 last year
6M ago
ACIU

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >